SCHEMBL1194168

SCHEMBL1194168

CCOC(=O)C(C#N)NC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.41
ALDH1A1 P00352 5/20 0.39
LMNA P02545 3/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.37
GAA P10253 3/20 0.37
MGAM O43451 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
CAD P27708 1/20 0.35
HTT P42858 2/20 0.35
PKM P14618 2/20 0.34
KDM4E B2RXH2 1/20 0.34
THRB P10828 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1564967 1.00 SOAT1 (0.41) SOAT1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL7601775 0.88 ALDH1A1 (0.39) SOAT1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL2775866 0.83 RXFP1 (0.39) SOAT1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL1968575 0.83 RXFP1 (0.39) SOAT1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL2829956 0.81 APOBEC3G (0.43) ALDH1A1LMNATSHRGAAMGAM
SCHEMBL4957669 0.81 APOBEC3G (0.43) ALDH1A1LMNATSHRGAAMGAM
SCHEMBL7162041 0.81 SOAT1 (0.41) SOAT1ALDH1A1LMNAHSD17B10GAA
SCHEMBL3203978 0.80 MMP8 (0.36) ALDH1A1LMNATSHRGAAMGAM
SCHEMBL1967339 0.80 KMT2A (0.41) ALDH1A1TSHRGAAMGAMSI
SCHEMBL20838333 0.80 ALDH1A1 (0.39) SOAT1ALDH1A1LMNAHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107311939-B Preparation method of substituted pyrimidone derivative 南京科技职业学院 2020-05-22 CN claimed
JP-55108883-A None JP disclosed
US-12617789-B2 Small molecular inhibitors of NF-κb inducing kinase JANSSEN PHARMACEUTICA NV (BE) 2026-05-05 US disclosed
US-20260001924-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME NEW YORK UNIVERSITY (US) 2026-01-01 US disclosed
US-12371461-B2 Nemo coiled coil mimics and methods of using same NEW YORK UNIVERSITY (US) 2025-07-29 US disclosed
EP-3303367-B1 STABILIZED MINIMAL COILED-COIL MIMETICS UNIV NEW YORK (US) 2025-06-18 EP disclosed
EP-4467199-A2 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE JANSSEN Pharmaceutica NV (BE) 2024-11-27 EP disclosed
CN-118908957-A Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-11-08 CN disclosed
EP-3976597-B1 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2024-08-28 EP disclosed
CN-114222737-B Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-07-26 CN disclosed
EP-0021234-A1 Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone, their preparation and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1981-01-07 EP disclosed
US-4234571-A CONTRACEPTIVES, ANTIFERTILITY AGENTS SYNTEX (U.S.A.) INC. (US) 1980-11-18 US disclosed
JP-S55108883-A ETHYL-(GAMMA-ACETAMINO-GAMMA-ETHOXYCARBONYL-GAMMA-CYANOPROPYL- METHYL) PHOSPHINATE AND ITS PREPARATION NISSAN CHEM IND LTD 1980-08-21 JP disclosed
US-4206216-A Antihypertensive N-heterocyclicalanines MERCK & CO., INC. (US) 1980-06-03 US disclosed
US-4170654-A Antihypertensive compositions containing N-heterocyclicalanines and α- MERCK & CO., INC. (US) 1979-10-09 US disclosed
US-4160835-A Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid MERCK & CO., INC. (US) 1979-07-10 US disclosed
US-4156734-A Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid MERCK & CO., INC. (US) 1979-05-29 US disclosed
US-4153715-A Indolyl amino acids useful as antihypertensive agents MERCK & CO., INC. (US) 1979-05-08 US disclosed
US-4065572-A Amino acids and esters thereof useful as antihypertensive agents MERCK & CO., INC. (US) 1977-12-27 US disclosed
US-4058642-A HYPERTENSIVE BOEHRINGER INGELHEIM GMBH (DT) 1977-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12371461-B2 Nemo coiled coil mimics and methods of using same COIL, CALCOCO2, NCAPH SOAT1 4475/4885ALDH1A1 3890/4885LMNA 170/4885
US-12617789-B2 Small molecular inhibitors of NF-κb inducing kinase IRAK3, IKBKB, IKBKG SOAT1 702/4885ALDH1A1 3824/4885LMNA 3314/4885
US-20260001924-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME DDX21, PHAX, RBX1 SOAT1 3519/4885ALDH1A1 4748/4885LMNA 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.